BRPI0819889A2 - Viral vector, composition, vaccine, vaccine composition, kit, processes for the preparation of a viral vector and for the preparation of a composition, use of a viral vector, and method of treatment - Google Patents

Viral vector, composition, vaccine, vaccine composition, kit, processes for the preparation of a viral vector and for the preparation of a composition, use of a viral vector, and method of treatment

Info

Publication number: BRPI0819889A2
Authority: BR; Brazil
Prior art keywords: composition; viral vector; preparation; vaccine; kit
Prior art date: 2007-12-06

Application number

BRPI0819889-6A

Other languages

Portuguese (pt)

Inventor

Joseph D Cohen

Martine Marchand

Original Assignee

Glaxosmithkline Biolog Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-06

Filing date

2008-12-04

Publication date

2015-06-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40591828&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0819889(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-12-04 Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa

2015-06-16 Publication of BRPI0819889A2 publication Critical patent/BRPI0819889A2/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Tropical Medicine & Parasitology (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Biotechnology (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Immunology (AREA)
Virology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biochemistry (AREA)
Mycology (AREA)
Epidemiology (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Plant Pathology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)

BRPI0819889-6A 2007-12-06 2008-12-04 Viral vector, composition, vaccine, vaccine composition, kit, processes for the preparation of a viral vector and for the preparation of a composition, use of a viral vector, and method of treatment BRPI0819889A2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US99280207P	2007-12-06	2007-12-06
PCT/EP2008/066762 WO2009071613A2 (en)	2007-12-06	2008-12-04	Vaccine

Publications (1)

Publication Number	Publication Date
BRPI0819889A2 true BRPI0819889A2 (en)	2015-06-16

Family

ID=40591828

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0819889-6A BRPI0819889A2 (en)	2007-12-06	2008-12-04	Viral vector, composition, vaccine, vaccine composition, kit, processes for the preparation of a viral vector and for the preparation of a composition, use of a viral vector, and method of treatment

Country Status (20)

Country	Link
EP (1)	EP2227550A2 (en)
JP (1)	JP2011505796A (en)
KR (1)	KR20100108544A (en)
CN (1)	CN101939438A (en)
AR (1)	AR069568A1 (en)
AU (1)	AU2008333208A1 (en)
BR (1)	BRPI0819889A2 (en)
CA (1)	CA2707245A1 (en)
CL (1)	CL2008003614A1 (en)
CO (1)	CO6300795A2 (en)
CR (1)	CR11537A (en)
DO (1)	DOP2010000164A (en)
IL (1)	IL205953A0 (en)
MA (1)	MA32003B1 (en)
MX (1)	MX2010006207A (en)
PE (1)	PE20091106A1 (en)
TW (1)	TW200938633A (en)
UY (1)	UY31510A1 (en)
WO (1)	WO2009071613A2 (en)
ZA (1)	ZA201003851B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0815872D0 (en) *	2008-09-01	2008-10-08	Pasteur Institut	Novel method and compositions
GB201016471D0 (en) *	2010-09-30	2010-11-17	Isis Innovation	Viral vector immunogenic compositions
EA027236B1 (en) *	2011-04-08	2017-07-31	Иммьюн Дизайн Корп.	Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
CN110687289B (en) *	2019-10-17	2023-04-18	中国人民解放军陆军军医大学	Application of FGL2 protein as malaria infection marker

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040136963A1 (en) *	2001-06-22	2004-07-15	The Trustees Of The University Of Pennsylvania	Simian adenovirus vectors and methods of use
JP5404990B2 (en) *	2002-10-23	2014-02-05	グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム	How to vaccinate against malaria
SG156535A1 (en) *	2002-12-17	2009-11-26	Crucell Holland Bv	Recombinant viral-based malaria vaccines
WO2005063805A1 (en) *	2003-12-23	2005-07-14	The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Antibodies against the amino terminus region of circumsporozoite protein prevent the onset of malaria infection
ATE449105T1 (en) *	2004-01-23	2009-12-15	Angeletti P Ist Richerche Bio	CHIMPANZEE ADENOVIRUS VACCINE CARRIAGE
EP1802336B1 (en) *	2004-10-14	2011-09-07	Crucell Holland B.V.	Malaria prime/boost vaccines
GB0513421D0 (en) *	2005-06-30	2005-08-03	Glaxosmithkline Biolog Sa	Vaccines
EP1998804B1 (en) *	2006-03-27	2014-04-16	Crucell Holland B.V.	Compositions comprising a recombinant adenovirus and an adjuvant
KR20090092752A (en) *	2006-07-18	2009-09-01	글락소스미스클라인 바이오로지칼즈 에스.에이.	Vaccines for malaria
EP2998316B1 (en) *	2007-03-02	2019-06-12	GlaxoSmithKline Biologicals S.A.	Novel method and compositions
GB0706914D0 (en) *	2007-04-10	2007-05-16	Isis Innovation	Novel adenovirus vectors

2008
- 2008-12-04 AR ARP080105281A patent/AR069568A1/en not_active Application Discontinuation
- 2008-12-04 WO PCT/EP2008/066762 patent/WO2009071613A2/en not_active Ceased
- 2008-12-04 PE PE2008002018A patent/PE20091106A1/en not_active Application Discontinuation
- 2008-12-04 AU AU2008333208A patent/AU2008333208A1/en not_active Abandoned
- 2008-12-04 KR KR1020107014859A patent/KR20100108544A/en not_active Withdrawn
- 2008-12-04 TW TW097147198A patent/TW200938633A/en unknown
- 2008-12-04 MX MX2010006207A patent/MX2010006207A/en not_active Application Discontinuation
- 2008-12-04 EP EP08857977A patent/EP2227550A2/en not_active Withdrawn
- 2008-12-04 UY UY31510A patent/UY31510A1/en unknown
- 2008-12-04 CN CN2008801267101A patent/CN101939438A/en active Pending
- 2008-12-04 BR BRPI0819889-6A patent/BRPI0819889A2/en not_active IP Right Cessation
- 2008-12-04 CA CA2707245A patent/CA2707245A1/en not_active Abandoned
- 2008-12-04 JP JP2010536451A patent/JP2011505796A/en active Pending
- 2008-12-04 CL CL2008003614A patent/CL2008003614A1/en unknown
2010
- 2010-05-25 IL IL205953A patent/IL205953A0/en unknown
- 2010-05-28 ZA ZA2010/03851A patent/ZA201003851B/en unknown
- 2010-06-02 DO DO2010000164A patent/DOP2010000164A/en unknown
- 2010-06-10 CO CO10070274A patent/CO6300795A2/en not_active Application Discontinuation
- 2010-06-29 CR CR11537A patent/CR11537A/en not_active Application Discontinuation
- 2010-07-05 MA MA32991A patent/MA32003B1/en unknown

Also Published As

Publication number	Publication date
CN101939438A (en)	2011-01-05
KR20100108544A (en)	2010-10-07
CL2008003614A1 (en)	2010-01-15
MA32003B1 (en)	2011-01-03
MX2010006207A (en)	2010-10-04
JP2011505796A (en)	2011-03-03
ZA201003851B (en)	2012-11-28
UY31510A1 (en)	2009-08-03
DOP2010000164A (en)	2010-07-31
WO2009071613A2 (en)	2009-06-11
CR11537A (en)	2010-08-18
EP2227550A2 (en)	2010-09-15
AR069568A1 (en)	2010-02-03
CA2707245A1 (en)	2009-06-11
AU2008333208A1 (en)	2009-06-11
TW200938633A (en)	2009-09-16
WO2009071613A3 (en)	2009-08-13
IL205953A0 (en)	2010-11-30
PE20091106A1 (en)	2009-08-24
CO6300795A2 (en)	2011-07-21

Similar Documents

Publication	Publication Date	Title
BR112012003578A2 (en)	2015-09-08	compound, pharmaceutically acceptable salt, sulfate salt, pharmaceutical composition, method for treating a viral infection, and use of a compound or salt.
BRPI0918487A2 (en)	2015-12-01	process for the preparation of a copolymer composition, composition, and use of a copolymer composition
BRPI1010775A2 (en)	2016-03-22	composition, method for preparing a composition, and use of a composition.
BRPI0817265A2 (en)	2015-06-16	RNA vaccine, use of at least one RNA molecule, and isolated RNA molecule
BRPI0916884A2 (en)	2016-06-14	immunogenic composition, process for preparing an immunogenic composition, use of an immunogenic composition, and kit
BRPI0911685A2 (en)	2015-10-13	compound, method for treating a disease, use of a compound, pharmaceutical composition, and kit
DK2207775T3 (en)	2012-06-18	4-Benzylamino-1-carboxyacylpiperidine derivatives as CETP inhibitors useful in the treatment of diseases such as hyperlipidemia or arteriosclerosis
BRPI0916235A2 (en)	2018-03-13	compound, pharmaceutical composition, use of the compound or composition, and method for treating an hcv infected patient
BR112013022927A2 (en)	2016-12-06	composition, methods for replacing or supplementing or modifying a subject's microbiota of the colon, and for treating a subject, and, use of a composition
BRPI0813627A2 (en)	2014-12-23	ANTIMICROBIAN PEPTIDIA, COMPOSITIONS AND METHODS OF USE
BRPI0811635A2 (en)	2014-11-11	ARILAZOL-2-IL CYANOETHYLAMINE COMPOUNDS, METHODS FOR MAKING THEM AND METHODS FOR THE USE OF THEM
BR112012016398A2 (en)	2018-08-21	Substituted imidazopyridinyl-aminopyridine compound, pharmaceutical composition comprising said compound and use thereof for the treatment of a proliferative cell disease
BRPI0819218A2 (en)	2015-05-05	Methods, kits and compositions for administering pharmaceutical compounds
BRPI0813770A2 (en)	2014-12-30	COMPOSITION, AND, USE OF A COMPOSITION
BRPI0816330A2 (en)	2015-04-14	Polypeptide composition, method for producing polypeptide composition, polypeptide construct, method for producing a polypeptide construct, nucleic acid construct, medicament or vaccine composition, method for producing a medicament or vaccine composition, and use of the polypeptide composition , a polypeptide construct, a nucleic acid construct or a medicament or vaccine composition
BRPI0922233A2 (en)	2018-05-29	compounds, pharmaceutical compositions and methods for use in the treatment of metabolic syndromes.
BRPI0912539A2 (en)	2015-10-13	compound, pharmaceutical composition, method for treating a disease, and use of the compound.
CL2007001630A1 (en)	2008-02-08	COMPOUNDS DERIVED FROM PIRROLIDINAMIDE; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF HEPATITIS C.
BR112012004173A2 (en)	2017-05-30	"compound, composition, method for preparing a composition, and use of a compound"
BRPI0808813A2 (en)	2016-08-02	method for the preparation of rubber compounds, and use of compounds
DK2041069T3 (en)	2012-02-27	Benzylamines, processes for their preparation and their use as anti-inflammatory agents
DK2216021T3 (en)	2012-11-05	PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OVERACTIVE BLOWER
BR112012024638A2 (en)	2015-09-15	use of a graft copolymer, composition, method for preparing the composition and method for controlling
BRPI0807536A2 (en)	2014-06-10	PROCESSES FOR PREPARING COMPOUND, PREPARING A MIXTURE, AND USING A MIXTURE
BRPI1007624A2 (en)	2016-07-26	compound, method of preparing a pharmaceutically acceptable salt, composition or salt thereof and use of a pharmaceutically acceptable salt or compound thereof

Legal Events

Date	Code	Title	Description
2015-12-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.
2016-04-05	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.